HomeCompareIPMLF vs MRK

IPMLF vs MRK: Dividend Comparison 2026

IPMLF yields 35.97% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IPMLF wins by $128.0K in total portfolio value
10 years
IPMLF
IPMLF
● Live price
35.97%
Share price
$5.56
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$185.7K
Annual income
$28,708.73
Full IPMLF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — IPMLF vs MRK

📍 IPMLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIPMLFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IPMLF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IPMLF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IPMLF
Annual income on $10K today (after 15% tax)
$3,057.55/yr
After 10yr DRIP, annual income (after tax)
$24,402.42/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, IPMLF beats the other by $15,805.71/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IPMLF + MRK for your $10,000?

IPMLF: 50%MRK: 50%
100% MRK50/50100% IPMLF
Portfolio after 10yr
$121.7K
Annual income
$19,411.26/yr
Blended yield
15.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

IPMLF
No analyst data
Altman Z
2.1
Piotroski
7/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IPMLF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIPMLFMRK
Forward yield35.97%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$185.7K$57.7K
Annual income after 10y$28,708.73$10,113.78
Total dividends collected$135.2K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IPMLF vs MRK ($10,000, DRIP)

YearIPMLF PortfolioIPMLF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$14,297$3,597.12$11,213$373.04+$3.1KIPMLF
2$20,104$4,806.40$12,667$512.06+$7.4KIPMLF
3$27,828$6,316.51$14,439$708.14+$13.4KIPMLF
4$37,947$8,171.24$16,640$988.16+$21.3KIPMLF
5$51,017$10,413.61$19,432$1,394.07+$31.6KIPMLF
6$67,673$13,084.39$23,057$1,992.90+$44.6KIPMLF
7$88,631$16,220.61$27,889$2,894.79+$60.7KIPMLF
8$114,689$19,854.20$34,518$4,286.29+$80.2KIPMLF
9$146,728$24,010.79$43,912$6,494.35+$102.8KIPMLF
10$185,708$28,708.73$57,714$10,113.78+$128.0KIPMLF

IPMLF vs MRK: Complete Analysis 2026

IPMLFStock

Imperial Metals Corporation, a mining company, engages in the acquisition, exploration, development, mining, and production of base and precious metals in Canada. It holds 100% interests in the Mount Polley copper-gold mine that includes seven mining leases and 50 mineral claims covering an area of 23,369 hectares located in south-central British Columbia; and the Huckleberry copper mine, which comprises two mining leases and 49 mineral claims covering an area of 25,767 hectares situated in west-central British Columbia. The company also holds a 30% interest in the Red Chris copper-gold mine located in northwest British Columbia. In addition, it holds a 100% interest in the Ruddock Creek lead-zinc property in British Columbia, as well as a portfolio of 23 greenfield exploration properties in British Columbia. Imperial Metals Corporation was incorporated in 1959 and is headquartered in Vancouver, Canada.

Full IPMLF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this IPMLF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IPMLF vs SCHDIPMLF vs JEPIIPMLF vs OIPMLF vs KOIPMLF vs MAINIPMLF vs JNJIPMLF vs ABBVIPMLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.